Abstract:Importance: The clinical features of the follicular subtype of ocular adnexal lymphoma (OAL) have not been previously evaluated in a large cohort. Objective: To characterize the clinical features of follicular OAL. Design, setting, and participants: We performed a retrospective multicenter study that involved 6 eye cancer centers from January 1, 1980, through December 31, 2010. A total of 105 patients with follicular OAL were identified, of which 7 patients were excluded because of missing clinical data. The median follow-up time was 52 months (range, 13-118 months). Main outcomes and measures: Overall survival, disease-specific, and progression-free survivals were the primary end points. Results: Ninety-eight eligible patients with follicular OAL were included; 60 (61%) were women. The median patient age was 63 years (range, 32-96 years). Sixty-nine patients (70%) had primary OAL, 19 (19%) had OAL in conjunction with a concurrent systemic lymphoma, and 10 (10%) presented with an ocular adnexal relapse. The lacrimal gland (28%), conjunctiva (28%), and orbit (28%) were the most frequently involved sites. Of the 69 patients with primary follicular lymphoma, 38 (55%) presented with Ann Arbor stage IE lymphoma, and 31 (45%) had stage IIE lymphoma. Patients with disseminated lymphoma had stage IIIE (9 of 19 [47%]) and stage IV (10 of 19 [53%]) disease, whereas patients with a relapse of systemic lymphoma presented with stage IE (8 of 10 [80%]), stage IIE (1 of 10 [10%]), and stage IIIE (1 of 10 [10%]) disease. Patients with primary follicular lymphoma (n = 69) and those with isolated ocular relapse (n = 9) were treated with external beam radiation therapy (EBRT) (35 of 78 [45%]) or EBRT plus chemotherapy (22 of 78 [28%]). Patients presenting with stage IIIE-IV follicular lymphoma (n = 20) most frequently received chemotherapy (9 of 20 [45%]) or EBRT plus chemotherapy (4 of 20 [20%]). The 10-year overall survival for the entire study cohort was 60%. Primary patients treated with EBRT had a better disease-specific survival compared with patients receiving ERBT plus chemotherapy (10-year disease-specific survival, 94% vs 40%; P = .02 by log-rank test). Conclusions and relevance: Follicular OAL was more commonly found in elderly female patients. These tumors were equally noted to involve the conjunctiva, lacrimal gland, and orbit. Patients with ocular adnexal follicular lymphoma primarily treated with EBRT had a more favorable long-term disease-specific survival.

Prognostic factors for relapse and survival among patients with ocular adnexal lymphoma: validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM classification

Specific location of ocular adnexal lymphoma and mortality: an international multicentre retrospective study

Orbital and ocular adnexal lymphoma: a review of epidemiology and prognostic factors in Taiwan

Long-Term Survival and Factors Associated with Increased Mortality in Patients with Ocular Adnexal Lymphomas

Primary, unilateral ocular adnexal lymphoma: disease progression and long-term survival

Ocular adnexal follicular lymphoma: a multicenter international study

Ocular adnexal lymphoma: A single-institution retrospective study

The prognostic value of lymph node metastasis and the eighth edition of AJCC for patients with anaplastic thyroid cancer

Development and validation of a novel TNM staging N‐classification of oral cavity squamous cell carcinoma

Assessment of prognostic factors in patients with primary ocular adnexal lymphoma when considering competing risk elements

Validation of the Postneoadjuvant Therapy Pathological Stage of the American Joint Committee on Cancer (AJCC) 8th Edition for Predicting Outcomes of Esophageal Squamous Cell Carcinoma (ESCC) Patients Receiving Neoadjuvant Chemoradiotherapy (CRT) Followed by Esophagectomy.

Validation and Suggestion of Eighth T Classifications of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma Patients: a Retrospective Analysis

Ultra-low-dose radiotherapy in the treatment of ocular adnexal lymphoma: a prospective study

Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017

Refining the eighth edition AJCC TNM classification and prognostic groups for papillary thyroid cancer with lateral nodal metastasis

Long-Term Clinical Outcomes in Treatment-Naïve Patients With Orbital Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma: A Single-Center Study

Staging soft tissue sarcoma of the head and neck: Evaluation of the AJCC 8th edition revised T classifications

Paediatric ocular adnexal lymphoma: a population-based analysis

Validation Study for the N Descriptor of the Newly Proposed Ninth Edition of the TNM Staging System Proposed by the International Association for the Study of Lung Cancer

Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort

Rates of Positive Findings on Positron Emission Tomography and Bone Marrow Biopsy in Patients With Ocular Adnexal Lymphoma